An interventional study of Beverage in Body Weight, sponsored by Purdue University. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-21.
Sponsored by Purdue University · Not applicable, Interventional, and Basic science
The aim of this study will be to compare the effects of daily consumption of aspartame, rebaudioside a, saccharin, sucralose, and sucrose on body weight and composition in a standardized protocol. The investigators hypothesize that individual low calorie sweeteners (consumed in a beverage) differ from each other in promoting weight loss and decreased fat mass (without energy restriction or dietary guidance) based on their chemical structure.
1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.
This study's enrollment of 187 is above the median of 64 across 947 interventional studies indexed under Body Weight.
Browse Body Weight studies →Purdue University is the lead sponsor of 168 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
100-140 g sucrose/day
Dietary Supplement: Beverage
0.541-0.757 g aspartame Sweetened Beverage/day
Dietary Supplement: Beverage
0.300-0.455 g saccharin Sweetened Beverage/day
Dietary Supplement: Beverage
0.167-0.233 g sucralose Sweetened Beverage/day
Dietary Supplement: Beverage
0.250-0.350 g rebaudioside A Sweetened Beverage/day
Dietary Supplement: Beverage
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
Body Weight
Time frame: 12 weeks
Body Composition
Duel emission X-ray absorbtiometry
Time frame: 12 weeks
Energy Intake
24 hr Dietary Recall
Time frame: 12 weeks
Appetite
24 hr visual analog scale appetite
Time frame: 12 weeks
Energy Expenditure
accelerometer
Time frame: 12 weeks
Plan to share: Undecided
This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Purdue University